Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Delcath Systems Inc (DCTH)

Delcath Systems Inc (DCTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Delcath Systems Inc 566 QUEENSBURY AVENUE QUEENSBURY NY 12804 USA

www.delcath.com Employees: 96 P: 518-743-8892

Sector:

Medical

Description:

Delcath Systems, Inc. has developed a system, the Delcath system, to isolate the liver from the general circulatory system and to administer chemotherapy and other therapeutic agents directly to the liver.

Key Statistics

Overview:

Market Capitalization, $K 320,706
Enterprise Value, $K 277,256
Shares Outstanding, K 34,746
Float, K 28,700
% Float 82.60%
Short Interest, K 4,037
Short Float 11.62%
Days to Cover 7.07
Short Volume Ratio 0.38
% of Insider Shareholders 17.40%
% of Institutional Shareholders 61.12%

Financials:

Annual Sales, $ 85,230 K
Annual Net Income, $ 2,700 K
Last Quarter Sales, $ 20,730 K
Last Quarter Net Income, $ -1,900 K
EBIT, $ 660 K
EBITDA, $ -690 K

Growth:

1-Year Return -30.83%
3-Year Return 96.05%
5-Year Return -51.16%
5-Year Revenue Growth 5,065.45%
5-Year Earnings Growth 100.84%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.02 on 11/04/25
Next Earnings Date 05/14/26
Earnings Per Share ttm 0.07
EPS Growth vs. Prev Qtr -350.00%
EPS Growth vs. Prev Year -200.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-700 on 12/24/19

DCTH Ratios

Ratio
Price/Earnings ttm 122.86
Price/Earnings forward 14.83
Price/Earnings to Growth N/A
Return-on-Equity % 2.63%
Return-on-Assets % 2.39%
Profit Margin % 3.17%
Debt/Equity 0.00
Price/Sales 3.51
Price/Cash Flow 164.52
Price/Book 2.73
Book Value/Share 3.15
Interest Coverage 0.20
60-Month Beta 0.38
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar